These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas. Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117-8. PubMed ID: 3917709 [No Abstract] [Full Text] [Related]
13. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)]. Bercovici JP; Khoury S; Tater D; Besson G; Caroff J Biomed Pharmacother; 1983; 37(5):222-7. PubMed ID: 6661508 [TBL] [Abstract][Full Text] [Related]
14. Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Ikegami H; Aono T; Koizumi K; Koike K; Fukui H; Tanizawa O Fertil Steril; 1987 May; 47(5):867-9. PubMed ID: 3569564 [No Abstract] [Full Text] [Related]
15. Giant invasive prolactinoma: a case report and review of nine further cases. Davis JR; Sheppard MC; Heath DA Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731 [TBL] [Abstract][Full Text] [Related]
16. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009 [TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia and prolactinoma. Romijn JA Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588 [TBL] [Abstract][Full Text] [Related]
18. [Clinical presentation, diagnostics and results of primary conservative treatment of large and giant prolactin-secreting pituitary adenomas]. Astaf'eva LI; Kadashev BA; Kalinin PL; Kutin MA; Shkarubo AN; Fomichev DV; Faĭzullaev RB; Alekseev SN; Sidneva IuG; Tenedieva VD; Tropinskaia OF Zh Vopr Neirokhir Im N N Burdenko; 2008; (4):36-8; discussion 39. PubMed ID: 19230480 [TBL] [Abstract][Full Text] [Related]
19. Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists. Neff LM; Weil M; Cole A; Hedges TR; Shucart W; Lawrence D; Zhu JJ; Tischler AS; Lechan RM Pituitary; 2007; 10(1):81-6. PubMed ID: 17285366 [TBL] [Abstract][Full Text] [Related]
20. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment. Ribeiro RS; Abucham J Eur J Endocrinol; 2009 Jul; 161(1):163-9. PubMed ID: 19359408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]